RXO, Inc.RXONYSE

|||

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts are neutral — opinion is divided on direction.

Consensus Rating

Hold

15 analysts·Moderate coverage

27%

Rating Distribution

Strong Buy

00%

Buy

427%

Hold

1067%

Sell

17%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Price is near analyst consensus — limited near-term upside expected.

Bear Case

$11.00

-29%

Consensus

$16.20

+5%

Bull Case

$19.00

+23%

Price Range15 analysts

Low

Consensus

High

$11.00

$19.00

Current Target

Current Price

$15.49

Upside to Target

$0.71

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$0.09(12 analysts)

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev+6.54%

EPS+400.24%

FY2028

Rev+7.16%

EPS+20.76%

Earnings Surprises

Beat rate:67%(8/12 quarters)

Avg surprise:+48.4%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Jan 15, 2026Truist Financial

RXO Inc. price target lowered to $18 from $20 at Truist

Target:$18.00

+16.9%from $15.39

Jan 8, 2026Susquehanna

RXO Inc. price target raised to $11 from $10 at Susquehanna

Target:$11.00

-21.7%from $14.04

Dec 16, 2025Stifel Nicolaus

RXO Inc. price target raised to $16 from $15 at Stifel

Target:$16.00

+6.5%from $15.02

Nov 11, 2025Morgan Stanley

RXO Inc. upgraded to Overweight from Equal Weight at Morgan Stanley

Target:$19.00

+56.0%from $12.18

Oct 14, 2025Truist Financial

RXO Inc. price target raised to $22 from $20 at Truist

Target:$22.00

+31.3%from $16.75

Oct 10, 2025Stifel Nicolaus

RXO Inc. price target raised to $17 from $14 at Stifel

Target:$17.00

-3.7%from $17.66

Oct 3, 2025UBS

RXO Inc. price target raised to $17 from $15 at UBS

Target:$17.00

+6.4%from $15.97

Jun 24, 2025Susquehanna

RXO Inc. price target raised to $12 from $10 at Susquehanna

Target:$12.00

-25.2%from $16.05

Apr 24, 2025Truist Financial

RXO Inc. price target lowered to $19 from $24 at Truist

Target:$19.00

+39.6%from $13.62

Mar 7, 2025Deutsche Bank

RXO Inc. initiated with a Hold at Deutsche Bank

Target:$19.00

-4.1%from $19.81

Jan 7, 2025Wells Fargo

RXO Inc. price target lowered to $28 from $31 at Wells Fargo

Target:$28.00

+10.7%from $25.30

Nov 18, 2024Goldman Sachs

Goldman Sachs Reinstates RXO, Inc. (RXO) at Neutral

Target:$29.00

+1.0%from $28.72

Oct 8, 2024Citigroup

RXO Inc. initiated with a Buy at Citi

Target:$33.00

+19.5%from $27.62

Sep 26, 2024Susquehanna

RXO Inc. price target lowered to $16 from $20 at Susquehanna

Target:$16.00

-42.6%from $27.88

Sep 17, 2024Oppenheimer

Oppenheimer Reiterates Outperform Rating on RXO, Inc. (RXO)

Target:$31.00

+19.4%from $25.96

Sep 11, 2024Jefferies

Jefferies Reiterates Buy Rating on RXO, Inc. (RXO)

Target:$31.00

+22.7%from $25.26

Jul 8, 2024Stephens

RXO Inc. price target raised to $25 from $22 at Stephens

Target:$25.00

-6.6%from $26.77

Jun 25, 2024Stifel Nicolaus

RXO, Inc. (RXO) PT Raised to $26 at Stifel

Target:$26.00

+4.8%from $24.81

Jun 24, 2024Jefferies

RXO, Inc. (RXO) PT Raised to $30 at Jefferies

Target:$30.00

+20.7%from $24.85

Jun 20, 2024UBS

UBS Reiterates Neutral Rating on RXO, Inc. (RXO)

Target:$22.00

+9.7%from $20.06

Apr 11, 2024Wolfe Research

RXO Inc. price target lowered to $15 from $16 at Wolfe Research

Target:$15.00

-29.8%from $21.38

Jun 9, 2023Susquehanna

Evaluating RXO's Potential: Analyst Highlights Company's Robust Balance Sheet and FCF Conversion Rate

Target:$20.00

-8.6%from $21.88

Dec 20, 2022Wells Fargo

Wells Fargo Initiates Coverage On RXO with Equal-Weight Rating, Announces Price Target of $18

Target:$18.00

+10.0%from $16.36

Dec 9, 2022Morgan Stanley

Morgan Stanley Initiates Coverage On RXO with Equal-Weight Rating, Announces Price Target of $20

Target:$20.00

+12.4%from $17.80

Dec 6, 2022Jefferies

Jefferies Initiates Coverage On RXO with Buy Rating, Announces Price Target of $25

Target:$25.00

+39.5%from $17.91

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance